GlassScriptPhysician profile
Tracey E Kolund
NPI 1992024400
$1,931.47
in general payments reported to CMS, 2019-2025
15 companies · $272 in 2025
The $272 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $181 · 2022: $444 · 2023: $321 · 2024: $714 · 2025: $272.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,307.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,306.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Myriad Genetic Laboratories, INC. | $311.65 | 2022-2024 | Myrisk, Mychoice Cdx |
| Glaxosmithkline, LLC. | $305.29 | 2021-2025 | Zejula, Jemperli |
| Merck Sharp & Dohme LLC | $268.24 | 2021-2025 | Keytruda, Lynparza |
| Abbvie INC. | $258.25 | 2024-2025 | |
| Eisai INC. | $243.68 | 2022-2025 | |
| Seagen INC. | $218.81 | 2022-2023 | Tivdak |
| Astrazeneca Pharmaceuticals LP | $98.67 | 2022-2025 | Lynparza |
| Immunogen, INC. | $46.35 | 2023 | Elahere |
| Pfizer INC. | $44.92 | 2024-2025 | |
| Fennec Pharmaceuticals, INC. | $33.64 | 2025 | Fyarro |
| Sanara Medtech INC. | $28.00 | 2024 | Celleraterx |
| Kci USA, INC. | $27.22 | 2023 | Activ.A.C. Ion Progress, Prevena, V.A.C. Dermatac |
| Clovis Oncology, INC. | $17.39 | 2021 | |
| Integra Lifesciences Corporation | $15.23 | 2024 | Cusa Clarity, Codman Certas, Codman Hakim |
| Astellas Pharma US INC | $14.13 | 2023 | Veozah |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tracey Kolund listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.